title: [Antibacterial activity of pefloxacin in the urine during the 7 days following a single 800 mg oral dose].
abstract: Antibacterial activity of pefloxacin was studied in the urine after a single 800 mg oral dose in ten healthy female volunteers. Urine was collected in 9 periods: 0-6 h, 6-12 h, 12-24 h, 24-28 h, 48-72 h, 72-96 h, 96-120 h, 120-144 h, 144-168 h. Pefloxacin concentrations were assayed in all samples by a microbiological method and by HPLC. Urine antibacterial activity was determined towards five bacterial strains isolated in urine: 2 E. Coli strains, one sensitive and the other resistant to nalidixic acid (Nal-A), 1 Klebsiella pneumoniae resistant to nalidixic acid (Nal-B), 1 Staphylococcus saprophyticus and 1 Streptococcus faecalis; MIC's of pefloxacin against these strains were respectively 0.015, 0.25, 1, 0.50 and 2 micrograms/ml. Pefloxacin mean concentrations as determined by the microbiological method were 91.8 +/- 11.9, 71.7 +/- 7, 44.5 +/- 4.3, 24.4 +/- 4 and 5.4 +/- 0.8 micrograms/ml in the five first urine samples; low levels were present in the urine until the 7th day in 8 volunteers. HPLC results completed the already known data concerning pefloxacin elimination and metabolism; unchanged pefloxacin was excreted at the highest concentration during the 6 first hours; then demethylpefloxacin was eliminated at higher levels than pefloxacin with a ratio of 2/1 after the 24th hour. These two compounds were detectable in the urine during 5 to 7 days; oxodemethylpefloxacin and N-oxyde-pefloxacin were present in lower amounts and during a shorter period.(ABSTRACT TRUNCATED AT 250 WORDS)
authors.affiliation: Service de Microbiologie Médicale, Hôpital Saint-Joseph, Paris.
authors.forename: J
authors.initials: J
authors.lastname: Guibert
authors.forename: M D
authors.initials: MD
authors.lastname: Kitzis
authors.forename: I
authors.initials: I
authors.lastname: Brumpt
authors.forename: J F
authors.initials: JF
authors.lastname: Acar
mesh_terms: D000284:Administration, Oral; D000328:Adult; D004334:Drug Administration Schedule; D013293:Enterococcus faecalis / Q000187:drug effects*; D004926:Escherichia coli / Q000187:drug effects*; D005260:Female; D006801:Humans; D007711:Klebsiella pneumoniae / Q000187:drug effects*; D008875:Middle Aged; D015366:Pefloxacin / Q000008:administration & dosage / Q000494:pharmacology / Q000652:urine*; D013210:Staphylococcus / Q000187:drug effects*
chemical_list: D015366:Pefloxacin
vernacular_title: Activité antibactérienne de la péfloxacine dans l'urine durant sept jours après prise orale unique de 800 mg.